Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Scandinavian Journal of Gastroenterology
|
August 28, 2003
Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis
S Distante, M Elmberg, K B Foss Haug, et al.
Eclinicalmedicine
|
April 28, 2022
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial
U Strömberg, C Bonander, M Westerberg, et al.
Alimentary Pharmacology & Therapeutics
|
September 6, 2000
Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis
G Järnerot, M Ström, A Danielsson, et al.
Journal of Viral Hepatitis
|
February 18, 2010
The burden of hepatitis C in Sweden: a national study of inpatient care
A-S Duberg, H Pettersson, S Aleman, et al.
Gut
|
April 1, 1996
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
U Broomé, R Olsson, L Lööf, et al.
Tissue Antigens
|
July 30, 2002
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis
R Wassmuth, F Depner, A Danielsson, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1994
Cancer risk in primary biliary cirrhosis: a population-based study from Sweden
L Lööf, H O Adami, P Sparén, et al.
Gastroenterology
|
June 1, 1996
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis
R Löfberg, A Danielsson, O Suhr, et al.
Scandinavian Journal of Gastroenterology
|
June 1, 1996
Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells
D Grandér, R Hultcrantz, O Weiland, et al.
Alimentary Pharmacology & Therapeutics
|
January 7, 2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia
L Lindström, K M Boberg, O Wikman, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Scandinavian Journal of Gastroenterology
|
August 28, 2003
Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis
S Distante, M Elmberg, K B Foss Haug, et al.
Eclinicalmedicine
|
April 28, 2022
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial
U Strömberg, C Bonander, M Westerberg, et al.
Alimentary Pharmacology & Therapeutics
|
September 6, 2000
Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis
G Järnerot, M Ström, A Danielsson, et al.
Journal of Viral Hepatitis
|
February 18, 2010
The burden of hepatitis C in Sweden: a national study of inpatient care
A-S Duberg, H Pettersson, S Aleman, et al.
Gut
|
April 1, 1996
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
U Broomé, R Olsson, L Lööf, et al.
Tissue Antigens
|
July 30, 2002
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis
R Wassmuth, F Depner, A Danielsson, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1994
Cancer risk in primary biliary cirrhosis: a population-based study from Sweden
L Lööf, H O Adami, P Sparén, et al.
Gastroenterology
|
June 1, 1996
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis
R Löfberg, A Danielsson, O Suhr, et al.
Scandinavian Journal of Gastroenterology
|
June 1, 1996
Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells
D Grandér, R Hultcrantz, O Weiland, et al.
Alimentary Pharmacology & Therapeutics
|
January 7, 2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia
L Lindström, K M Boberg, O Wikman, et al.
Page
of 9